Make Alzheimer’s a Distant Memory
A simple test could change the future of Alzheimer’s care — and you can help us make breakthroughs to detect this disease earlier than ever. Discover how you can be a part of a groundbreaking study to help put Alzheimer’s in the past.Click Here to Check Your Eligibility
Introducing the DAVOS Alzheimer’s Collaborative Study
When it comes to Alzheimer’s disease, we believe you deserve answers earlier to stay well ahead of memory issues for longer. That’s why the AdventHealth Research Institute has joined forces with global partners to revolutionize Alzheimer’s care through the DAVOS Alzheimer’s Collaborative study. The first of its kind in the U.S., this study goes beyond a memory test and aims to improve early detection and delay mental decline in millions of people worldwide.
Advancing Alzheimer's Care for the Future
Discover how we're aiming to transform Alzheimer's care through research that identifies the disease earlier than ever before.
All Your Questions, Answered by Our Team
If you’re 65 years of age or older and have not been diagnosed with dementia, you may qualify to be part of the groundbreaking study.
As with all of our research studies:
- Whether or not to take part is up to you
- You can choose not to take part (there will be no penalty or loss of benefits to which you are otherwise entitled)
- You can agree to take part and later change your mind (there will be no penalty or loss of benefits to which you are otherwise entitled)
- If you are an employee of AdventHealth, your participation or lack of participation in this study will not affect your employment or relationship with AdventHealth
At every stage of life, having a healthy brain is essential to leading a fulfilling life. As people grow older, memory issues become more common. Around the world, we know that more people are developing Alzheimer’s, a disease that affects a person’s brain health, causing memory issues.
That’s why we’re conducting this exciting new research study to assess health care preparedness in the early detection of Alzheimer’s disease. Brain testing through clinical research can give us more accurate answers than a short-term memory loss test.
Clinical research gives us a stronger understanding of what causes Alzheimer’s and how to advance Alzheimer’s care. Our goals of this study are:
- To detect biomarkers that are associated with Alzheimer’s disease in individuals with memory impairment
- To allow for early intervention that could slow cognitive decline
- To change the future of Alzheimer’s care by creating systems that will make these assessments part of routine health exams
If you are eligible for the study and agree to take part, you will confirm via an e-consent form to take an online assessment of cognition called Cogstate Brief Battery. To access Cogstate Brief Battery, you will be asked to provide more information, like your name, age and email address.
After registration, you will receive an email within three days to take the online brain function test called Cogstate Brief Battery. The Cogstate Brief Battery is an assessment of your cognition using playing cards. It will take you approximately 10 to 15 minutes to complete.
Once you complete the online assessment, we’ll determine if you meet eligibility for the second part of this study. If you do meet the requirements, you’ll be invited to participate in the second part of the study, which takes place in person at the research site. If you choose to participate in this part of the study, you will be given a separate written consent and will be compensated for your time and effort.
We cannot promise any benefits to you or others from your taking part in this research. You may not directly benefit from this research; however, we hope that your participation in the study may improve how we care for Alzheimer’s disease patients.
The DAVOS Alzheimer’s Collaborative Study and AdventHealth will provide the online assessment of cognition, Cogstate Brief Battery, at no charge during this study.
Participating in this study is the primary way you can help us with this research, meaning your alternative is to not take part. This research study is not designed to diagnose, treat or prevent any disease.
As a physician, you can help your patients stay well ahead of brain health concerns by encouraging their participation in the DAVOS Alzheimer’s Collaborative study. With simple CLIA (lab certification) and FDA-approved methods, the study aims to identify Alzheimer’s biomarkers, allowing for early intervention that could slow cognitive decline.
Patients 65 years of age or older who have not been diagnosed with dementia may qualify to be part of the study.
This important study can help inform and improve Alzheimer’s care for physicians everywhere. We’re aiming to:
- Detect biomarkers that indicate your risk for developing Alzheimer’s
- Allow for early intervention that could slow cognitive decline
- Change the future of Alzheimer’s care by creating systems that will make these assessments part of routine health exams
Explore More Active Research Studies
The AdventHealth Research Institute has over 500 active studies covering all facets of research, including medication development, surgical techniques, treatment methods and more. Our expert team of physicians and researchers is dedicated to the highest levels of safety and quality as we advance clinical research and breakthroughs.Find a Study